Hoffmann Bernhard
SEC CIK 1830354 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IRD | Opus Genetics, Inc. | SVP of Corp. Dev, Ops, Sec | 185.4K | — | — | 5 | 2023-01-10 | 2025-03-13 |
Most active insiders at IRD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Foundation Fighting Blindness Retinal Degeneration Fund | Dir, See Remarks | — | $15.99M |
| 2 | Gallagher Cam | Dir | $323.9K | — |
| 3 | Magrath George | CEO, Dir | — | $204.9K |
| 4 | Gagnon Robert E. | CFO | — | $190.8K |
| 5 | YERXA BENJAMIN R | Pres, Dir | — | $61.2K |
| 6 | Jayagopal Ashwath | Chief Scientific, Dev. Ofc | — | $58.2K |
| 7 | SCHACHLE JOSEPH K | COO | — | $57.7K |
| 8 | Zaremba Rabourn Amy | Head of Fin. Quality Assurance | — | $23.3K |
| 9 | Bennett Jean | Dir | — | — |
| 10 | Ainsworth Sean | Dir | — | — |
Hoffmann Bernhard made no open-market trades at IRD in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-17 | 2025-03-13 | IRD | Opus Genetics, Inc. | Hoffmann Bernhard | SVP of Corp. Dev | A - Grant | $0.00 | +29.5K | 185.4K | +19% | $0 |
| 2025-02-06 | 2025-02-04 | IRD | Opus Genetics, Inc. | Hoffmann Bernhard | SVP of Corp. Dev | F - Tax | $1.14 | -6,751 | 155.9K | -4% | -$7,696 | |
| D | 2024-01-22 | 2024-01-18 | IRD | Opus Genetics, Inc. | Hoffmann Bernhard | SVP of Corp. Dev | A - Grant | $0.00 | +20.0K | 162.7K | +14% | $0 |
| 2024-01-12 | 2024-01-10 | IRD | Opus Genetics, Inc. | Hoffmann Bernhard | SVP of Corp. Dev | F - Tax | $3.27 | -4,031 | 142.7K | -3% | -$13.2K | |
| D | 2023-01-12 | 2023-01-10 | IRD | Opus Genetics, Inc. | Hoffmann Bernhard | SVP of Corp. Dev, Ops, Sec | A - Grant | $0.00 | +46.6K | 146.7K | +47% | $0 |
Purchase Sale Sale after option exercise All abbreviations